Hello. Well, with this stock...honestly, there is no "normal". The only saving grace to todays action is the fact that it appears biotech in general is getting pummelled. RNA's primary competitor, SRPT, was down almost 12% at one point today (although, as of this post has rallied back to be down only 6%).
The action on this stock never makes sense. Will it get back to $7.00, I don't know the answer to that. Holding a long position, I would like to believe so. There are currently 3 analyst ratings on this with $12, $11 and $7.40 price targets respectively. I am hoping to at least see a bounce back to the 50 day moving average around $6.29 today, but I'm not holding my breath for that.
Good Luck.
News 
Market Data 
Discover 
